Detalhe da pesquisa
1.
A multicenter randomized-controlled trial of hypothermic oxygenated perfusion (HOPE) for human liver grafts before transplantation.
J Hepatol
; 78(4): 783-793, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36681160
2.
Molecular response patterns in relapsed/refractory AML patients treated with selinexor and chemotherapy.
Ann Hematol
; 102(2): 323-328, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36576532
3.
A Phase II study of selinexor plus cytarabine and idarubicin in patients with relapsed/refractory acute myeloid leukaemia.
Br J Haematol
; 190(3): e169-e173, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32515072
4.
Selinexor (KPT-330), an Oral Selective Inhibitor of Nuclear Export (SINE) Compound, in Combination with FOLFOX in Patients with Metastatic Colorectal Cancer (mCRC) - Final Results of the Phase I Trial SENTINEL.
Curr Cancer Drug Targets
; 20(10): 811-817, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32598257